Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: Thc - The Untold Story

How Is DaVita's Stock Performance Compared to Other Healthcare Stocks

DaVita has outperformed other healthcare stocks over the past year, and analysts remain moderately optimistic about its growth prospects.

Barchart

Is HCA Healthcare Stock Underperforming the S&P 500?

Despite HCA Healthcare’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

3 Oversold Healthcare Stocks to Buy After Jobs Data

Strong healthcare job growth is boosting sentiment. These three oversold healthcare stocks offer defensive stability and upside potential for investors

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

How Is HCA Healthcare's Stock Performance Compared to Other Healthcare Providers Stocks?

HCA Healthcare has outperformed the Healthcare Providers industry over the past year, and analysts are moderately optimistic about the stock’s prospects.

Barchart

Texas proposes 13,000% licensing fee hike on retailers who sell hemp-derived THC

Hemp advocates say raising annual licensing fees for retailers from $150 to $20,000 and for manufacturers from $250 to $25,000 would shutter small businesses.

The Texas Tribune

Centene, Cigna, Others Drop As Molina's Results Rattle Sector

Molina Healthcare Inc. (NYSE:MOH) missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.

Benzinga

These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results

Tenet Healthcare Corporation (NYSE:THC) posted better-than-expected earnings for the second quarter on Tuesday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Top Analyst-Rated Healthcare Stocks to Watch Now

While the healthcare sector has been remarkably stable, three firms in particular stand out for a closer look as the second half of 2025 approaches.

MarketBeat

3 High-Beta Stocks for Aggressive Investors

High-Beta stocks, characterized by high risk levels, potential for high returns and growth, are favored by investors having high-risk tolerance and seeking high returns. Thus, quality high-beta stocks Devon Energy (DVN), Marathon Oil (MRO), and Tenet Healthcare (THC) could be ideal for aggressive investors. Continue reading.

StockNews.com

3 Unexpected AI Stocks to Buy and Hold for Long-Term Gains

As AI takes center stage, investors might want to snag these three under-the-radar AI stocks for long-term growth.

Barchart

Will These 3 Medical Stocks Make Gains in 2024?

Technological advances, rising healthcare costs, and the robust demand for medicines and healthcare services due to an aging population and the rise in chronic diseases are boosting the prospects of the medical sector. So, should you invest in Walgreens Boots Alliance (WBA), Tenet Healthcare (THC) and LifeVantage (LFVN) for gains?…

StockNews.com

Holiday Outlook: 3 Medical Stocks to Consider Buying

The medical sector is expected to grow amid steady demand and technological advancements. Given the solid long-term prospects of the industry, fundamentally sound medical stocks Tenet Healthcare (THC), Semler Scientific (SMLR) and FONAR (FONR) could be ideal buys for steady gains. Read on.

StockNews.com

3 Medical Stock Gainers Worth a Look

The US medical industry is set to soar, driven by a burgeoning aging population and innovations in healthcare. So, fundamentally strong medical stocks Encompass Health (EHC), Tenet Healthcare (THC), and HCA Healthcare (HCA) might be solid buys for healthy returns. Read more.

StockNews.com

5 Medical Stocks Creating Healthy Returns for Investors

The medical industry has experienced tremendous growth in recent years and should continue to grow amid the integration of advanced technologies. Hence, fundamentally strong medical stocks HCA Healthcare (HCA), Fresenius SE (FSNUY), Tenet Healthcare (THC), Encompass Health (EHC), and Select Medical Holdings (SEM) might be ideal buys to garner healthy…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Medical Stocks to Buy for Value

The medical industry is well-positioned for significant growth thanks to robust demand. Moreover, given the recession concerns, medical stocks could be defensive investments. Therefore, investors could look to buy fundamentally strong medical stocks Fresenius SE & Co. (FSNUY), Tenet Healthcare (THC), and Select Medical Holdings (SEM), which are currently trading…

StockNews.com

3 Hospital Stocks to Look Into

Given the recession-resistant nature of the healthcare industry and the long-term tailwinds from advanced technologies and an aging population, investors could keep an eye on quality hospital stocks HCA Healthcare (HCA), Universal Health Services (UHS), and Tenet Healthcare Corp. (THC) for a healthy portfolio. Read more….

StockNews.com

Boost Your Profits This Week With HCA Healthcare (HCA)

Hospital operator HCA Healthcare (HCA) could receive a boost in its profits due to its continuous efforts to bolster its portfolio. So, it could be wise to invest in the stock now. Let’s look at some of its key financial metrics….

StockNews.com

3 Best Performing Medical Stocks to Add to Your Rotation in April

With advancements in technology and increased demand for healthcare services, now may be the perfect time to invest in fundamentally strong medical stocks, HCA Healthcare (HCA), Fresenius SE & Co (FSNUY), and Tenet Healthcare (THC), which seem well-positioned to capitalize on the industry’s tailwinds. Read more….

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Tenet Healthcare Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Tenet Healthcare. Looking at options history for Tenet Healthcare (NYSE:THC) we detected 12 strange trades.

Benzinga

Short Volatility Alert: Tenet Healthcare Corporation

On Thursday, shares of Tenet Healthcare Corporation (NYSE: THC) experienced volatile short activity. After the activity, the stock price went down -7.10% to $52.56. The overall sentiment for THC has been Bearish.

Benzinga

Icanic Brands Signs Non-Binding LOI To Acquire DNA Organics, Here Are The Terms

Icanic Brands Company, Inc. (OTCQB: ICNAF) (CSE:ICAN) has signed a non-binding letter of interest to acquire DNA Organics, Inc. (“Lifted”).

Benzinga

Sipp Industries Launches THC Nano-Infused Medicinal Body Lotion, Claims It Has 95% Bio-Availability

Sipp Industries, Inc. (OTCPK:SIPC) has received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the “Aveina” brand.

Benzinga

Why This Analyst Thinks HCA Healthcare Was 'Well Oversold' After Revised Outlook

RBC Capital Market reduced the target price for HCA Healthcare Inc (NYSE:HCA) from $291 to $267 (26.5% upside), noting the shares were well oversold on Friday (-22%) after a ~5.5% guide-down on known labor headwinds. The analysts continue to view the labor backdrop as largely transitory and believe HCA management is well equipped to…

Benzinga

Why This Analyst Thinks Tenet Healthcare's 'Q1 In Line On Solid Execution'

RBC Capital Markets views Tenet Healthcare Corp's (NYSE:THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds. The analysts have raised the price target from $89 to $104 (41% upside) with an Outperform rating. Against an increasingly difficult labor backdrop characterized by high agency utilization, Tenet could hold…

Benzinga

Tenet Healthcare Clocks 43% Jump In Q1 Profit Despite Flat Sales, Q2 Profit Outlook Trails Consensus

Tenet Healthcare Corp's (NYSE:THC) Q1 FY22 adjusted EPS came in at $1.93, up from $1.30 a year ago and beating the management guidance of $0.92 - $1.15. Net operating revenue hit $4.74 billion, marginally down 0.75% Y/Y, beating the consensus of $4.71 billion. Management expected sales of $4.6 billion - $4.8 billion. Adjusted…

1 2

People

Dipanjan BanchurSince

722 stories

Steve Reitmeister

508 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.